ASIT Biotech Overview

  • Year Founded
  • 1997

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 127

Employees

  • Latest Deal Type
  • M&A

  • Investors
  • 1

ASIT Biotech General Information

Description

European Medical Solutions Formerly DMS Imaging SA is a clinical-stage biopharmaceutical company. The company is engaged in the development and future commercialization of a range of breakthrough immunotherapy products for the treatment of allergies, based on its ASIT+ technology platform. Its lead product is gp-ASIT+, a phase III trial for the treatment of grass pollen rhinitis. Its pipeline products consist of hdm-ASIT+ for the treatment of house dust mite asthma; and pnt-ASIT+ for the treatment of peanut allergy.

Contact Information

Website
www.asitbiotech.com
Formerly Known As
BioTech Tools
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Rue des Chasseurs-Ardennais 7
  • 4031 Liege
  • Belgium
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
European Medical Solutions
Vertical(s)
Life Sciences
Corporate Office
  • Rue des Chasseurs-Ardennais 7
  • 4031 Liege
  • Belgium

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ASIT Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 11-Jan-2021 Completed Generating Revenue
5. PIPE 23-Feb-2018 Completed Generating Revenue
4. Grant 12-Dec-2016 Completed Generating Revenue
3. IPO 11-May-2016 Completed Generating Revenue
2. Early Stage VC 24-Oct-2000 Completed Product Development
1. University Spin-Out 01-May-1997 Completed Startup
To view ASIT Biotech’s complete valuation and funding history, request access »

ASIT Biotech Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
European Medical Solutions Formerly DMS Imaging SA is a clinical-stage biopharmaceutical company. The company is engaged
Drug Discovery
Liege, Belgium
127 As of 2025

Yardley, PA
 

North Chicago, IL
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ASIT Biotech Competitors (21)

One of ASIT Biotech’s 21 competitors is Savara, a Formerly VC-backed company based in Yardley, PA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Savara Formerly VC-backed Yardley, PA
AbbVie Corporation North Chicago, IL
Avalyn Pharma Formerly VC-backed Boston, MA
Bristol-Myers Squibb Corporation Princeton, NJ
Biocon Formerly PE-Backed Bengaluru, India
You’re viewing 5 of 21 competitors. Get the full list »

ASIT Biotech Patents

  • 134

    Total Documents Applications and Grants

  • Total Patents Families

  • 34

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

ASIT Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2019264459-A1 Evaluation of hydrolyzed allergen preparations Inactive 30-Apr-2018
CA-3098781-A1 Evaluation of hydrolyzed allergen preparations Inactive 30-Apr-2018
EP-3788367-A1 Evaluation of hydrolyzed allergen preparations Inactive 30-Apr-2018
US-20210123905-A1 Evaluation of hydrolyzed allergen preparations Inactive 30-Apr-2018
WO-2019211312-A1 Evaluation of hydrolyzed allergen preparations Inactive 30-Apr-2018 G01N33/5052
To view ASIT Biotech’s complete patent history, request access »

ASIT Biotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ASIT Biotech Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Epimède Venture Capital Minority
Horizon 2020 Government
Noshaq Venture Capital Minority
Société Régionale d'Investissement de Wallonie Growth/Expansion Minority
To view ASIT Biotech’s complete investors history, request access »

Ready to get started?

Request a free trial

ASIT Biotech ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view ASIT Biotech’s complete esg history, request access »

ASIT Biotech FAQs

  • When was ASIT Biotech founded?

    ASIT Biotech was founded in 1997.

  • Where is ASIT Biotech headquartered?

    ASIT Biotech is headquartered in Liege, Belgium.

  • What is the size of ASIT Biotech?

    ASIT Biotech has 127 total employees.

  • What industry is ASIT Biotech in?

    ASIT Biotech’s primary industry is Drug Discovery.

  • Is ASIT Biotech a private or public company?

    ASIT Biotech is a Private company.

  • What is ASIT Biotech’s current revenue?

    The current revenue for ASIT Biotech is .

  • How much funding has ASIT Biotech raised over time?

    ASIT Biotech has raised $43.8M.

  • Who are ASIT Biotech’s investors?

    Epimède, Horizon 2020, Noshaq, and Société Régionale d'Investissement de Wallonie have invested in ASIT Biotech.

  • Who are ASIT Biotech’s competitors?

    Savara, AbbVie, Avalyn Pharma, Bristol-Myers Squibb, and Biocon are some of the 21 competitors of ASIT Biotech.

  • When was ASIT Biotech acquired?

    ASIT Biotech was acquired on 11-Jan-2021.

  • Who acquired ASIT Biotech?

    ASIT Biotech was acquired by European Medical Solutions.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process